The Learning Curve
The Learning Curve
HomeNewsIndia1.60 crore people to get the shots in phase-I: Tamil Nadu Minister

1.60 crore people to get the shots in phase-I: Tamil Nadu Minister

Talking to reporters at the ESI Hospital during a special camp as part of the dry run, he said it is being carried out to identify the problems and challenges of administering the vaccine.

January 02, 2021 / 19:17 IST

Tamil Nadu has taken steps to administer COVID-19 vaccine to 1.60 crore people across the state in the first phase, Health Minister Dr Vijayabhaskar said on Saturday.

Talking to reporters at the ESI Hospital during a special camp as part of the dry run, he said it is being carried out to identify the problems and challenges of administering the vaccine.

A total of 47,200 vaccine centres have been established and 21,200 health workers trained for the purpose, he said. At least 17 places in five districts have been identified for the trial run for which 425 workers have been trained, he said.

The vaccinated person has been asked to wait for 30 minutes for observation, he pointed out.

Six lakh health workers like doctors, nurses in 2,881 government hospitals and 35,403 private hospitals would be administered the vaccine in the first phase, he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Only one person in the state was found affected by the new strain of the virus reported in the UK, he said.

Local Administration Minister S P Velumani lauded the efforts of the medical teams and frontline workers for making the city safe, and thanked Palaniswami for sanctioning adequate funds to fight the virus and opening 'Amma' clinics in the district.

A function featuring a flower shower from a helicopter as part of 13th edition of Kovai Vizha by CII and Young Indians was organised at the hospital to honour the frontline workers who had served and sacrificed their lives during the pandemic.

Follow our full coverage of the coronavirus pandemic here.

PTI
first published: Jan 2, 2021 07:13 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347